In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Vanda Pharmaceuticals Inc’s stock clocked out at $4.70, down -0.21% from its previous closing price of $4.71. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 0.61 million shares were traded.
Ratios:
To gain a deeper understanding of VNDA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.37 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 31, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On July 11, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
Jefferies Downgraded its Buy to Hold on February 25, 2022, whereas the target price for the stock was revised from $24 to $12.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 27 ’25 when Polymeropoulos Mihael Hristos bought 10,000 shares for $4.76 per share. The transaction valued at 47,600 led to the insider holds 2,351,730 shares of the business.
Polymeropoulos Mihael Hristos bought 10,000 shares of VNDA for $47,650 on Feb 26 ’25. The President and CEO now owns 2,341,730 shares after completing the transaction at $4.76 per share. On Feb 25 ’25, another insider, Polymeropoulos Mihael Hristos, who serves as the President and CEO of the company, bought 10,000 shares for $4.46 each. As a result, the insider paid 44,640 and bolstered with 2,331,730 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 0.51.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.71. The 50-Day Moving Average of the stock is 2.35%, while the 200-Day Moving Average is calculated to be -7.23%.
Shares Statistics:
A total of 58.31M shares are outstanding, with a floating share count of 54.27M. Insiders hold about 6.94% of the company’s shares, while institutions hold 74.60% stake in the company.
